Current Assessment and Management of Retinoblastoma
Retinoblastoma is the most common intraocular malignancy in childhood. Diagnosis is currently made by ophthalmologists under general anesthesia as it is the gold standard for intraocular assessment. However, evaluations for extraocular disease are also necessary. Treatment strategies vary according...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
The Korean Society of Pediatric Hematology-Oncology
2019-04-01
|
Series: | Clinical Pediatric Hematology-Oncology |
Subjects: | |
Online Access: | https://doi.org/10.15264/cpho.2019.26.1.35 |
id |
doaj-b85620dda320418c94d666661ea2f7d2 |
---|---|
record_format |
Article |
spelling |
doaj-b85620dda320418c94d666661ea2f7d22020-11-25T01:44:06ZengThe Korean Society of Pediatric Hematology-OncologyClinical Pediatric Hematology-Oncology2233-52502019-04-01261354510.15264/cpho.2019.26.1.35cpho.2019.26.1.35Current Assessment and Management of RetinoblastomaHee Won Chueh0Department of Pediatrics, Dong-A University Hospital, Dong-A University School of Medicine, Busan, KoreaRetinoblastoma is the most common intraocular malignancy in childhood. Diagnosis is currently made by ophthalmologists under general anesthesia as it is the gold standard for intraocular assessment. However, evaluations for extraocular disease are also necessary. Treatment strategies vary according to the disease status. If a single eye is involved, the treatment goal is oriented to the removal of the tumor and prevention of relapse. In bilateral retinoblastoma, the main treatment goal is to save monocular vision and save life. This article will explore the available treatment options for retinoblastoma including enucleation, radiotherapy, local therapy, intravenous chemotherapy, intra-arterial injection and intra-vitreal injections. There were recent advances in our understanding on the genetic pathophysiology of the retinoblastoma protein gene in tumorigenesis, which may help developing future treatment. Early detection of retinoblastoma is important for prolonging survival and improving quality of life.https://doi.org/10.15264/cpho.2019.26.1.35enucleationintra-arterial injectionintra-vitreal chemotherapyretinoblastomastem cell transplantation |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Hee Won Chueh |
spellingShingle |
Hee Won Chueh Current Assessment and Management of Retinoblastoma Clinical Pediatric Hematology-Oncology enucleation intra-arterial injection intra-vitreal chemotherapy retinoblastoma stem cell transplantation |
author_facet |
Hee Won Chueh |
author_sort |
Hee Won Chueh |
title |
Current Assessment and Management of Retinoblastoma |
title_short |
Current Assessment and Management of Retinoblastoma |
title_full |
Current Assessment and Management of Retinoblastoma |
title_fullStr |
Current Assessment and Management of Retinoblastoma |
title_full_unstemmed |
Current Assessment and Management of Retinoblastoma |
title_sort |
current assessment and management of retinoblastoma |
publisher |
The Korean Society of Pediatric Hematology-Oncology |
series |
Clinical Pediatric Hematology-Oncology |
issn |
2233-5250 |
publishDate |
2019-04-01 |
description |
Retinoblastoma is the most common intraocular malignancy in childhood. Diagnosis is currently made by ophthalmologists under general anesthesia as it is the gold standard for intraocular assessment. However, evaluations for extraocular disease are also
necessary. Treatment strategies vary according to the disease status. If a single eye is involved, the treatment goal is oriented to the removal of the tumor and prevention of relapse. In bilateral retinoblastoma, the main treatment goal is to save monocular vision and save life. This article will explore the available treatment options for retinoblastoma including enucleation, radiotherapy, local therapy, intravenous chemotherapy, intra-arterial injection and intra-vitreal injections. There were recent advances in our understanding on the genetic pathophysiology of the retinoblastoma protein gene in tumorigenesis, which may help developing future treatment. Early detection of retinoblastoma is important for prolonging survival and improving quality of life. |
topic |
enucleation intra-arterial injection intra-vitreal chemotherapy retinoblastoma stem cell transplantation |
url |
https://doi.org/10.15264/cpho.2019.26.1.35 |
work_keys_str_mv |
AT heewonchueh currentassessmentandmanagementofretinoblastoma |
_version_ |
1725029875161497600 |